Question 1

Who owns SCNI?

Accepted Answer

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) is held by 4 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is XTX Topco Ltd as of Q1 2026.

Question 2

Are institutions buying or selling SCNI?

Accepted Answer

In Q1 2026, 0 institutions opened or increased positions in SCINAI IMMUNOTHERAPEUTICS LT while 5 reduced or exited — a net selling quarter.

Question 3

What is the Smart Money Verdict on SCNI?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for SCINAI IMMUNOTHERAPEUTICS LT.

Question 4

How many hedge funds hold SCNI?

Accepted Answer

4 institutional investors report holding SCINAI IMMUNOTHERAPEUTICS LT (SCNI) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into SCNI?

Accepted Answer

As of Q1 2026, tracked institutions in SCINAI IMMUNOTHERAPEUTICS LT show 0 buyers versus 5 sellers — net outflows.

Fund	Action	Shares	Value	Weight	Est. P&L
XTX Topco Ltd	Decreased	24,041(-11.9%)	$13,283	0.0%	-65.28%
RHUMBLINE ADVISERS	Unchanged	1,878	$1,037	0.0%	-94.73%
UBS Group AG	Decreased	919(-47.4%)	$524	0.0%	-65.85%
MORGAN STANLEY	Unchanged	58	$33	0.0%	-91.01%
Virtu Financial LLC	Exited	0(-100.0%)	$11,000	0.0%	+11.11%
CITADEL ADVISORS LLC	Exited	0(-100.0%)	$24,612	0.0%	-45.95%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	Exited	0(-100.0%)	$712	0.0%	-33.33%

SCINAI IMMUNOTHERAPEUTICS LT

Continue exploring

Other Healthcare stocks held by institutions